← Back to Patent Explorer
US7189199B2 Expired / Lapsed US ⏱️ 0.0 years remaining

Methods and devices for improving cardiac function in hearts

Assignee: Edwards Lifesciences LLC
•
Filing: 2002-05-02
•
Granted: 2007-03-13
•
Expires: 2022-05-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Various methods and devices are disclosed for improving cardiac function in hearts having zones of infarcted (akinetic) and aneurysmal (dyskinetic) tissue regions. The methods and devices reduce the radius of curvature in walls of the heart proximal infarcted and aneurysmal regions to reduce wall stress and improve pumping efficiency. The inventive methods and related devices include splinting of the chamber wall proximal the infarcted region and various other devices and methods including suture and patch techniques.

Inventors

  • 👤 Patrick M. McCarthy
  • 👤 Cyril J. Schweich, Jr.
  • 👤 Todd J. Mortier
  • 👤 Peter T. Keith
  • 👤 Michael J. Kallok

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 16:30
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/02; A61F2/24; A61F2/2478; A61F2/2487; A61B; A61B17/00; A61B17/00234; A61B17/04; A61B17/0487; A61B17/12; A61B17/122; A61B17/1227; A61B2017/00238; A61B2017/00243; A61B17/0401; A61B2017/0404; A61B2017/0427; A61B2017/0435; A61B2017/0445; A61B2017/0446; A61B2017/0454; A61B2017/0458; A61B2017/0464; A61B17/0469; A61B2017/048; A61B2017/0496; A61B90/00; A61B90/39; A61B2090/392; A61F2/2481

Claims Analysis

Total Claims: 40
Claim 1
Independent Claim 107 words
A method of treating a heart valve, the method comprising: providing a device having an elongate member, the elongate member having a first end and a second end; positioning the elongate member transverse a heart chamber associated with the heart valve so as to reposition at least one leaflet associated with the heart valve, wherein, when the elongate member is positioned transverse the heart chamber, the elongate member does not contact each of papillary muscles, leaflets, and an annulus associated with the heart valve; and wherein the entire device is positioned solely above an apex of the heart and below an annulus associated with the heart valve.
Claim 2
Independent Claim 107 words
A method of treating a heart valve, the method comprising: providing a device having an elongate member, the elongate member having a first end and a second end; positioning the elongate member transverse a heart chamber associated with the heart valve so as to reposition at least one leaflet associated with the heart valve, wherein, when the elongate member is positioned transverse the heart chamber, the elongate member does not contact each of papillary muscles, leaflets, and an annulus associated with the heart valve; and wherein the entire device is positioned solely above an apex of the heart and below an annulus associated with the heart valve.
Claim 3
Dependent Claim 18 words
The method of claim 1 , further comprising fixing the elongate member in position transverse the heart chamber.
Claim 4
Dependent Claim 35 words
The method of claim 2 , wherein fixing the elongate member in position includes fixing the elongate member via at least one anchoring mechanism configured to be secured to a wall surrounding the heart chamber.
Claim 5
Dependent Claim 22 words
The method of claim 3 , wherein the anchoring mechanism is configured to be secured to an exterior surface of the wall.
Claim 6
Dependent Claim 47 words
The method of claim 2 , wherein an anchoring mechanism is provided on each of the first end and the second end of the elongate member and fixing the elongate member in position includes securing the anchoring mechanisms to portions of a wall surrounding the heart chamber.
Claim 7
Dependent Claim 23 words
The method of claim 1 , wherein positioning the elongate member includes positioning the elongate member transverse a left ventricle of the heart.
Claim 8
Dependent Claim 13 words
The method of claim 1 , wherein the valve is a mitral valve.
Claim 9
Dependent Claim 30 words
The method of claim 1 , wherein positioning the elongate member transverse the heart chamber includes positioning the elongate member so as to avoid internal structures of the heart chamber.
Claim 10
Dependent Claim 16 words
The method of claim 1 , wherein providing the elongate member includes providing a tension member.
Claim 11
Dependent Claim 22 words
The method of claim 1 , further comprising reducing a radius of curvature in at least a region of the heart chamber.
Claim 12
Dependent Claim 43 words
The method of claim 10 , wherein reducing the radius of curvature in at least a region of the heart chamber includes reducing the radius of curvature at one of an aneurysmal and an infracted region of a wall surrounding the heart chamber.
Claim 13
Independent Claim 158 words
A method of treating a heart valve, the method comprising: providing a device configured to be implanted proximate the heart valve; implanting the device such that a first portion of the device is positioned external to a heart chamber associated with the valve and closer to a first leaflet of the valve than to a second leaflet of the valve and such that a second portion of the device is positioned external to the heart chamber associated with the valve and closer to the second leaflet of the valve than the first leaflet of the valve; and repositioning at least one of the first leaflet and the second leaflet of the valve, wherein, when the device is implanted, the device does not contact each of papillary muscles, leaflets, and an annulus associated with the valve, and wherein the entire device is implanted solely above an apex of the heart and below an annulus associated with the heart valve.
Claim 14
Independent Claim 158 words
A method of treating a heart valve, the method comprising: providing a device configured to be implanted proximate the heart valve; implanting the device such that a first portion of the device is positioned external to a heart chamber associated with the valve and closer to a first leaflet of the valve than to a second leaflet of the valve and such that a second portion of the device is positioned external to the heart chamber associated with the valve and closer to the second leaflet of the valve than the first leaflet of the valve; and repositioning at least one of the first leaflet and the second leaflet of the valve, wherein, when the device is implanted, the device does not contact each of papillary muscles, leaflets, and an annulus associated with the valve, and wherein the entire device is implanted solely above an apex of the heart and below an annulus associated with the heart valve.
Claim 15
Dependent Claim 17 words
The method of claim 12 , further comprising drawing the first and second leaflets toward each other.
Claim 16
Dependent Claim 13 words
The method of claim 12 , wherein the valve is a mitral valve.
Claim 17
Dependent Claim 25 words
The method of claim 12 , wherein implanting the device includes implanting the device such that the first portion contacts a wall of the heart.
Claim 18
Dependent Claim 25 words
The method of claim 15 , wherein implanting the device includes implanting the device such that the second portion contacts a wall of the heart.
Claim 19
Dependent Claim 16 words
The method of claim 16 , wherein the wall surrounds a left ventricle of the heart.
Claim 20
Dependent Claim 29 words
The method of claim 16 , wherein implanting the device includes implanting the device such that the second portion contacts an exterior surface of the wall of the heart.
Claim 21
Dependent Claim 29 words
The method of claim 15 , wherein implanting the device includes implanting the device such that the first portion contacts an exterior surface of the wall of the heart.
Claim 22
Dependent Claim 15 words
The method of claim 12 , wherein providing the device includes providing an elongate member.
Claim 23
Dependent Claim 25 words
The method of claim 20 , wherein providing the elongate member includes providing a tension member configured to extend transverse a chamber of the heart.
Claim 24
Dependent Claim 38 words
The method of claim 20 , wherein the elongate member has a first end and a second end and providing the device further includes providing an anchoring mechanism on each of the first end and the second end.
Claim 25
Dependent Claim 22 words
The method of claim 22 , wherein implanting the device further comprises engaging the anchoring mechanisms with a wall of the heart.
Claim 26
Dependent Claim 21 words
The method of claim 22 , wherein the first portion and the second portion of the device include the anchoring mechanisms.
Claim 27
Independent Claim 149 words
A method of treating a heart valve having a first leaflet and a second leaflet, the method comprising: providing a device configured to be implanted proximate the heart valve; implanting the device such that a first portion of the device contacts heart structure located on a first side of a line defined by an intersection of the first leaflet and the second leaflet and such that a second portion of the device contacts heart structure located on a second side of the line opposite the first side; and repositioning at least one of the first leaflet and the second leaflet of the valve, wherein, when the device is implanted, the device does not contact each of papillary muscles, lealflets, and an annulus associated with the valve, and wherein the entire device is implanted solely above an apex of the heart and below an annulus associated with the heart valve.
Claim 28
Independent Claim 149 words
A method of treating a heart valve having a first leaflet and a second leaflet, the method comprising: providing a device configured to be implanted proximate the heart valve; implanting the device such that a first portion of the device contacts heart structure located on a first side of a line defined by an intersection of the first leaflet and the second leaflet and such that a second portion of the device contacts heart structure located on a second side of the line opposite the first side; and repositioning at least one of the first leaflet and the second leaflet of the valve, wherein, when the device is implanted, the device does not contact each of papillary muscles, lealflets, and an annulus associated with the valve, and wherein the entire device is implanted solely above an apex of the heart and below an annulus associated with the heart valve.
Claim 29
Dependent Claim 19 words
The method of claim 25 , further comprising drawing the first leaflet and the second leaflet toward each other.
Claim 30
Dependent Claim 13 words
The method of claim 25 , wherein the valve is a mitral valve.
Claim 31
Dependent Claim 25 words
The method of claim 25 , wherein implanting the device includes implanting the device such that the first portion contacts a wall of the heart.
Claim 32
Dependent Claim 25 words
The method of claim 28 , wherein implanting the device includes implanting the device such that the second portion contacts a wall of the heart.
Claim 33
Dependent Claim 16 words
The method of claim 29 , wherein the wall surrounds a left ventricle of the heart.
Claim 34
Dependent Claim 29 words
The method of claim 29 , wherein implanting the device includes implanting the device such that the second portion contacts an exterior surface of the wall of the heart.
Claim 35
Dependent Claim 29 words
The method of claim 28 , wherein implanting the device includes implanting the device such that the first portion contacts an exterior surface of the wall of the heart.
Claim 36
Dependent Claim 15 words
The method of claim 25 , wherein providing the device includes providing an elongate member.
Claim 37
Dependent Claim 25 words
The method of claim 33 , wherein providing the elongate member includes providing a tension member configured to extend transverse a chamber of the heart.
Claim 38
Dependent Claim 38 words
The method of claim 33 , wherein the elongate member has a first end and a second end and providing the device further includes providing an anchoring mechanism on each of the first end and the second end.
Claim 39
Dependent Claim 22 words
The method of claim 35 , wherein implanting the device further comprises engaging the anchoring mechanisms with a wall of the heart.
Claim 40
Dependent Claim 21 words
The method of claim 35 , wherein the first portion and the second portion of the device include the anchoring mechanisms.

References Cited (Backward Citations)

US963899A Cited
US3019790A Cited
US3656185A Cited
US3980068A Cited
US4055861A Cited
US4217665A Cited
US4035849A Cited
US4192293A Cited
US4261342A Cited
US4300564A Cited
US4343048A Cited
US4306319A Cited
US4372293A Cited
US4409974A Cited
US4536893A Cited
US4579120A Cited
US4592342A Cited
US4629459A Cited
US5496305A Cited
US4690134A Cited
US4705040A Cited
USRE34021E Cited
DE3614292C1 Cited
US5061277B1 Cited
US5061277A Cited
US4936857A Cited
EP0583012A1 Cited
EP0583012B1 Cited
US5156621A Cited
US4960424A Cited
US4944753A Cited
US5104407A Cited
US5104407B1 Cited
US6283993B1 Cited
US4997431A Cited
US5106386A Cited
WO1991019465A2 Cited
US5131905A Cited
US5389096A Cited
US5312642A Cited
US5360444A Cited
US5300087A Cited
US5169381A Cited
US5258015A Cited
US5584803A Cited
US5984857A Cited
US5192314A Cited
US5250049A Cited
US5376112A Cited
US5674279A Cited
US5758663A Cited
DE4234127C2 Cited
US5814097A Cited
US5718725A Cited
US5284488A Cited
US5522884A Cited
US6651671B1 Cited
US6125852A Cited
US6079414A Cited
US5452733A Cited
US5682906A Cited
US5571215A Cited
US20020029783A1 Cited
US5855614A Cited
US5665092A Cited
US5533958A Cited
US5385528A Cited
US5971911A Cited
US6258021B1 Cited
US5800334A Cited
US6572529B2 Cited
US5607471A Cited
WO1995006447A1 Cited
US5450860A Cited
WO1997024083A1 Cited
WO1997024082A1 Cited
WO1995016407A1 Cited
WO1995016476A1 Cited
US5458574A Cited
US5417709A Cited
US5445600A Cited
US5509428A Cited
WO1996002197A1 Cited
US5888240A Cited
US20010021874A1 Cited
US6217610B1 Cited
US5593424A Cited
WO1996004852A1 Cited
US5433727A Cited
US5972022A Cited
US5876436A Cited
US5840059A Cited
US5984917A Cited
US5865791A Cited
US6132438A Cited
US5849005A Cited
US6379366B1 Cited
WO1996040356A1 Cited
US5713954A Cited
US5800528A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2010-03-12 2010-09-11 2011-03-13 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2014-03-12 2014-09-11 2015-03-13 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2018-03-12 2018-09-11 2019-03-13 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag